PMN · ProMIS Neurosciences Inc.
$14.98
+0.32 (+2.18%)
At close · Aug 18
Going-concern doubt
— cleared Aug 13, 2026
The latest filing no longer states the doubt (first flagged May 12, 2026).
View the 10-Q filed Aug 13, 2026Market Cap
$128.96M
Shares
8.97M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-13 | Second Quarter 2026 Earnings Conference Call | Earnings call |
| 2026-07-28 | ProMIS’ Neurosciences Webinar on PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer’s Disease | Event |
| 2026-07-15 | Alzheimer’s Association International Conference (AAIC) | Conference |
| 2026-06-25 | BIO International Convention | Event |
| 2026-06-15 | H.C. Wainwright Neuro Perspectives Expert Summit | Event |
| 2026-06-10 | Oppenheimer CNS Summit | Event |
| 2026-06-04 | Virtual Alzheimer’s R&D Day, organized by Wolfe Research | Event |
Key facts
CIK
1374339
CUSIP
74346M505
13F (30d)
30 filings
28 filers
Visit website
Investor relations